• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

念珠菌属菌种:当前流行病学、致病性、生物膜形成、天然抗真菌产品和新的治疗选择。

Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.

机构信息

Department of Clinical Analysis, Laboratory of Clinical Mycology, Faculty of Pharmaceutical Sciences, UNESP, Araraquara, Brazil.

出版信息

J Med Microbiol. 2013 Jan;62(Pt 1):10-24. doi: 10.1099/jmm.0.045054-0. Epub 2012 Nov 22.

DOI:10.1099/jmm.0.045054-0
PMID:23180477
Abstract

The incidence of fungal infections has increased significantly, so contributing to morbidity and mortality. This is caused by an increase in antimicrobial resistance and the restricted number of antifungal drugs, which retain many side effects. Candida species are major human fungal pathogens that cause both mucosal and deep tissue infections. Recent evidence suggests that the majority of infections produced by this pathogen are associated with biofilm growth. Biofilms are biological communities with a high degree of organization, in which micro-organisms form structured, coordinated and functional communities. These biological communities are embedded in a self-created extracellular matrix. Biofilm production is also associated with a high level of antimicrobial resistance of the associated organisms. The ability of Candida species to form drug-resistant biofilms is an important factor in their contribution to human disease. The study of plants as an alternative to other forms of drug discovery has attracted great attention because, according to the World Health Organization, these would be the best sources for obtaining a wide variety of drugs and could benefit a large population. Furthermore, silver nanoparticles, antibodies and photodynamic inactivation have also been used with good results. This article presents a brief review of the literature regarding the epidemiology of Candida species, as well as their pathogenicity and ability to form biofilms, the antifungal activity of natural products and other therapeutic options.

摘要

真菌感染的发病率显著增加,导致发病率和死亡率上升。这是由于抗微生物药物耐药性的增加和抗真菌药物数量有限,这些药物仍然存在许多副作用。念珠菌属是主要的人类真菌病原体,可引起粘膜和深部组织感染。最近的证据表明,这种病原体引起的大多数感染与生物膜生长有关。生物膜是具有高度组织化的微生物群落,其中微生物形成结构、协调和功能的群落。这些生物群落嵌入在自我创造的细胞外基质中。生物膜的产生也与相关生物体的高水平抗微生物药物耐药性有关。念珠菌属形成耐药生物膜的能力是其对人类疾病贡献的一个重要因素。植物作为其他形式的药物发现替代物的研究引起了极大的关注,因为根据世界卫生组织的说法,这些是获得各种药物的最佳来源,可以使大量人群受益。此外,银纳米粒子、抗体和光动力失活也取得了良好的效果。本文简要回顾了关于念珠菌属的流行病学、致病性和生物膜形成能力、天然产物的抗真菌活性以及其他治疗选择的文献。

相似文献

1
Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.念珠菌属菌种:当前流行病学、致病性、生物膜形成、天然抗真菌产品和新的治疗选择。
J Med Microbiol. 2013 Jan;62(Pt 1):10-24. doi: 10.1099/jmm.0.045054-0. Epub 2012 Nov 22.
2
[Candida biofilm-related infections].[念珠菌生物膜相关感染]
Rev Iberoam Micol. 2016 Jul-Sep;33(3):176-83. doi: 10.1016/j.riam.2015.06.004. Epub 2015 Aug 17.
3
Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility.2011 年至 2016 年间在一家大型意大利大学医院观察到的念珠菌血流感染:基于时间的回顾性分析流行病学、生物膜产生、抗真菌药物消耗和药物敏感性。
PLoS One. 2019 Nov 7;14(11):e0224678. doi: 10.1371/journal.pone.0224678. eCollection 2019.
4
Future directions for anti-biofilm therapeutics targeting Candida.针对假丝酵母菌的抗生物膜治疗的未来方向。
Expert Rev Anti Infect Ther. 2014 Mar;12(3):375-82. doi: 10.1586/14787210.2014.885838. Epub 2014 Feb 9.
5
Management of Candida biofilms: state of knowledge and new options for prevention and eradication.念珠菌生物膜的管理:知识现状和预防及清除的新选择。
Future Microbiol. 2016;11(2):235-51. doi: 10.2217/fmb.15.139. Epub 2016 Feb 5.
6
Candida biofilms: antifungal resistance and emerging therapeutic options.念珠菌生物膜:抗真菌耐药性及新出现的治疗选择
Curr Opin Investig Drugs. 2004 Feb;5(2):186-97.
7
Antifungal activity against Candida biofilms.对念珠菌生物膜的抗真菌活性。
Int J Artif Organs. 2012 Oct;35(10):780-91. doi: 10.5301/ijao.5000170.
8
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms.从生物学到药物研发:应对真菌生物膜威胁的新方法。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MB-0007-2014.
9
Future therapies targeted towards eliminating Candida biofilms and associated infections.旨在消除念珠菌生物膜及相关感染的未来疗法。
Expert Rev Anti Infect Ther. 2017 Mar;15(3):299-318. doi: 10.1080/14787210.2017.1268530. Epub 2016 Dec 16.
10
Pathogenesis of Candida albicans biofilm.白色念珠菌生物膜的发病机制。
Pathog Dis. 2016 Jun;74(4):ftw018. doi: 10.1093/femspd/ftw018.

引用本文的文献

1
Bixin from L.: Analytical Method Validation, Physicochemical Characterization, and Selective Antifungal Activity against spp. .来自胭脂树属的胭脂树橙:分析方法验证、物理化学特性以及对……菌的选择性抗真菌活性
ACS Omega. 2025 Aug 15;10(33):37874-37888. doi: 10.1021/acsomega.5c04986. eCollection 2025 Aug 26.
2
Polymicrobial Biofilms: Interkingdom Interactions, Resistance and Therapeutic Strategies.多微生物生物膜:跨界相互作用、耐药性及治疗策略
Microb Biotechnol. 2025 Aug;18(8):e70218. doi: 10.1111/1751-7915.70218.
3
Wall incorporation of the β-1,3-glucan cross-linking protein Pir1 in the human pathogen Candida albicans is facilitated by the presence of two or more Pir repeat units.
在人类病原体白色念珠菌中,两个或更多的Pir重复单元的存在促进了β-1,3-葡聚糖交联蛋白Pir1整合到细胞壁中。
FEMS Yeast Res. 2025 Jan 30;25. doi: 10.1093/femsyr/foaf042.
4
Candida tropicalis-Associated Osteomyelitis in an Intravenous Drug User: A Case Report.一名静脉吸毒者的热带念珠菌相关性骨髓炎:病例报告
Cureus. 2025 Jul 7;17(7):e87438. doi: 10.7759/cureus.87438. eCollection 2025 Jul.
5
Insights into the evolution of Candidalysin and recent developments.念珠菌溶素的进化洞察及近期进展。
Arch Microbiol. 2025 Jul 31;207(9):206. doi: 10.1007/s00203-025-04414-z.
6
Multidrug-Resistant Candida in Bloodstream Infections: A Growing Concern in Indian Healthcare.血流感染中的多重耐药念珠菌:印度医疗保健领域日益关注的问题。
Cureus. 2025 Jun 5;17(6):e85420. doi: 10.7759/cureus.85420. eCollection 2025 Jun.
7
Efficacy of probiotics for oral candidiasis management: a systematic review.益生菌用于口腔念珠菌病治疗的疗效:一项系统评价
BMC Oral Health. 2025 Jul 2;25(1):1067. doi: 10.1186/s12903-025-06468-3.
8
In Vitro Evaluation of spp. and Sensitivity to 450 nm Diode Laser-Mediated Antimicrobial Photodynamic Therapy with Curcumin and Riboflavin.[物种名称]的体外评估以及对含姜黄素和核黄素的450纳米二极管激光介导抗菌光动力疗法的敏感性
Int J Mol Sci. 2025 Jun 12;26(12):5645. doi: 10.3390/ijms26125645.
9
Mechanism of recombinant 1,3-β-glucanase as antibiofilm to prevent antimicrobial resistance in antifungal therapy for vulvovaginitis candidiasis.重组1,3-β-葡聚糖酶作为抗生物膜剂在念珠菌性外阴阴道炎抗真菌治疗中预防抗菌药物耐药性的机制
Open Vet J. 2025 May;15(5):2182-2192. doi: 10.5455/OVJ.2025.v15.i5.36. Epub 2025 May 31.
10
Managing Candida auris in dialysis units: challenges, strategies, and future directions.透析单位中耳念珠菌的管理:挑战、策略及未来方向。
Int Urol Nephrol. 2025 Jun 13. doi: 10.1007/s11255-025-04600-4.